Shengwei Liu Selected Research

Shengwei Liu Research Topics

4	Brain Ischemia (Cerebral Ischemia) 07/2022 - 12/2019
3	Ischemic Stroke 07/2022 - 12/2019
3	Reperfusion Injury 05/2022 - 12/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2022 - 05/2021
2	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2017
2	Neoplasms (Cancer) 01/2021 - 11/2017
1	Lymphoma (Lymphomas) 05/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Cholecystolithiasis 01/2022
1	Choledocholithiasis 01/2022
1	Stroke (Strokes) 05/2021
1	Inflammation (Inflammations) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Atherosclerosis 01/2020
1	Infarction (Infarctions) 12/2019
1	Brain Diseases (Brain Disorder) 12/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2019
1	Alzheimer Disease (Alzheimer's Disease) 12/2019
1	Lymphatic Metastasis 09/2016
1	Hypoxia (Hypoxemia) 10/2010

3	Proteins (Proteins, Gene)FDA Link 07/2022 - 11/2017
2	caryophylleneIBA 07/2022 - 05/2021
2	Neuroprotective AgentsIBA 07/2022 - 12/2019
2	Caspase 3 (Caspase-3)IBA 05/2022 - 12/2019
2	Bexarotene (LGD1069)FDA Link 05/2022 - 12/2019
2	LigandsIBA 01/2020 - 11/2017
1	SesquiterpenesIBA 07/2022
1	Volatile Oils (Essential Oils)IBA 07/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 05/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 12/2019
1	ApolipoproteinsIBA 12/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2016
1	Estrogen ReceptorsIBA 09/2016
1	NitrogenIBA 10/2010

1	Laparoscopic Cholecystectomy 01/2022
1	Therapeutics 01/2021
1	Drug Therapy (Chemotherapy) 11/2017